NCT03971240

Traumatic Acute Subdural Haematoma: Management and Outcome

Status unknown NA Last updated 18 June 2019

What this trial tests

NA trial testing evacuation of traumatic acute subdural hematoma in Traumatic Brain Hemorrhage in 39 participants. Status unknown.

Timeline

1 September 2019

Primary endpoint
31 August 2020

31 January 2021

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	39
Start date	1 September 2019
Primary completion	31 August 2020
Estimated completion	31 January 2021

Drugs / interventions tested

• evacuation of traumatic acute subdural hematoma

Conditions studied

• Traumatic Brain Hemorrhage — all drugs for Traumatic Brain Hemorrhage →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Traumatic Brain Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Traumatic acute subdural haematomas (ASDHs) are common pathological entity in neurosurgical practice . The frequency of (ASDHs) has been proposed as approximately 10-20% of patients admitted with traumatic brain injury(TBI) .Approximately two -thirds of patient with TBI undergoing emergency cranial surgery have an acute subdural haematoma evacuated . Two common causes of traumatic ASDH: accumulation of blood around parenchymal laceration , usually frontal and temporal lobes and there is usually severe underlying brain injury .The second cause is surface or bridging vessel torn from cerebral acceleration - deceleration during violent head motion .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.